OverviewChartTechnicalNewsTraderScreen

Arcus Biosciences Inc/  US03969F1093  /

NYSE
2024-04-19  9:44:45 PM Chg. -0.37 Volume Bid9:44:45 PM Ask9:44:45 PM High Low
14.47USD -2.49% 326,324
Turnover: 3.48 mill.		 14.45Bid Size: 300 14.49Ask Size: 400 15.19 14.10
GlobeNewswire 01-17 Day One Announces Two New Appointments to Board of Directors
GlobeNewswire 2022-01-18 Fountain Therapeutics Announces Appointment of Anupama Hoey as Chief Business Officer
GlobeNewswire 2021-12-14 Myriad Genetics Promotes Nicole Lambert to Chief Operating Officer
GlobeNewswire 2021-11-22 Connect Biopharma Expands Executive Leadership Team with Hire of Chief Financial Officer
GlobeNewswire 2020-11-13 Surface Oncology Announces SRF617 and SRF388 Will Advance to Combination and Expansion Stages of Ong...
GlobeNewswire 2020-11-05 Xenon Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
GlobeNewswire 2020-07-16 Innate Pharma Announces the Appointment of Joyson Karakunnel, MD, MSC, FACP as Chief Medical Officer
GlobeNewswire 2020-06-18 Peter Svennilson Elected to RAPT Therapeutics Board of Directors
GlobeNewswire 2020-05-12 Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2020
GlobeNewswire 2020-03-17 Surface Oncology Announces First Patient Dosed in Clinical Trial of Immuno-Oncology Candidate SRF617
GlobeNewswire 2020-03-10 Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year...
GlobeNewswire 2020-01-09 Aravive Announces Management Changes
GlobeNewswire 2019-05-07 2019 Pipeline Review of 5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or EC 3.1.3.5)
GlobeNewswire 2019-05-02 Adverum Biotechnologies Announces Board Changes
GlobeNewswire 2019-04-18 Detailed Research: Economic Perspectives on Arcus Biosciences, Ion Geophysical, A.H. Belo, Buckle, S...
GlobeNewswire 2018-12-10 Droia Oncology Ventures raises second fund of EUR 150 million